Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ONENESS-BIOTECH-CO-LTD-13491432/news/US-FDA-genehmigt-klinische-Phase-2-Studie-fur-SNS812-eine-von-Oneness-Microbio-Shanghai-mitent-44501670/?utm_source=whatsapp&utm_medium=social&utm_campaign=share